SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended December 2024 remained nearly unchanged at Rs. 1465.52 millions.The Net Profit of the company registered a slight decline of -25.92% to Rs. 207.70  millions from Rs. 280.39 millions.The Operating Profit of the company witnessed a decrease to 326.34 millions from 406.78 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1465.52 1464.49 0.07 4550.48 4380.57 3.88 5805.50 5103.09 13.76
Other Income 89.70 110.18 -18.59 293.57 274.04 7.13 344.22 224.84 53.10
PBIDT 326.34 406.78 -19.77 1041.32 1089.26 -4.40 1343.30 1116.50 20.31
Interest 7.28 1.55 369.68 15.16 9.64 57.26 14.63 20.29 -27.90
PBDT 319.06 405.23 -21.26 1026.16 1079.62 -4.95 1328.67 1096.21 21.21
Depreciation 32.24 28.14 14.57 96.72 79.39 21.83 106.25 91.66 15.92
PBT 286.82 377.09 -23.94 929.44 1000.23 -7.08 1222.42 1004.55 21.69
TAX 79.12 96.70 -18.18 221.71 253.17 -12.43 289.38 275.56 5.02
Deferred Tax -1.33 24.60 -105.41 34.95 39.87 -12.34 34.95 15.86 120.37
PAT 207.70 280.39 -25.92 707.73 747.06 -5.26 933.04 728.99 27.99
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 22.27 27.78 -19.83 22.88 24.87 -7.97 23.14 21.88 5.76

Lincoln Pharma Share Price

645.40 -28.20 (-4.19%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×